Home
Piramal Pharma Ltd Quarterly Result

Piramal Pharma Ltd
NSE: PPLPHARMA
Net Profit - Last Quarter
Piramal Pharma Ltd Quarterly Results Key Highlights
- The revenue of Piramal Pharma Ltd for the Dec '24 is ₹ 2233 crore as compare to the Sep '24 revenue of ₹ 2320 crore.
- This represent the decline of -3.74%a1# The ebitda of Piramal Pharma Ltd for the Dec '24 is ₹ 366.92 crore as compare to the Sep '24 ebitda of ₹ 419.98 crore.
- This represent the decline of -12.63%a1# The net profit of Piramal Pharma Ltd for the Dec '24 is ₹ 3.68 crore as compare to the Sep '24 net profit of ₹ 22.59 crore.
- This represent the decline of -83.71%a1#.
Piramal Pharma Ltd Quarterly Results Analysis
Market Price of Piramal Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 208.6 |
20 Feb 2025 | 218.05 |
19 Feb 2025 | 200.45 |
18 Feb 2025 | 197.65 |
17 Feb 2025 | 199.85 |
14 Feb 2025 | 184.8 |
13 Feb 2025 | 200.9 |
12 Feb 2025 | 200.2 |
11 Feb 2025 | 204.35 |
10 Feb 2025 | 221.1 |
Historical Revenue of Piramal Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Piramal Pharma Ltd
Historical EBITDA of Piramal Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Piramal Pharma Ltd
Historical Net Profit of Piramal Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Piramal Pharma Ltd
Piramal Pharma Ltd News Hub
Piramal Pharma receives SBTi validation for its GHG commitment
Piramal Pharma has embarked on its sustainability journey as the Science Based Targets initiative (S
Read more
17 Sept 24
Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization
Read more
30 Sept 24
Piramal Pharma to discuss results
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe
Read more
14 Jan 25
Piramal Pharma to declare Quarterly Result
Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October 2024. Powe
Read more
15 Oct 24
Document
Concalls